Podoplanin is a type I transmembrane glycoprotein that is widely expressed in various tissues and cell types. It is known by several other names, including gp36, Aggrus, PA2.26 antigen, and T1 alpha. Podoplanin plays a crucial role in the development of the lymphatic system, cell migration, and tumor progression. The mouse anti-human podoplanin antibody is a monoclonal antibody that specifically targets human podoplanin, making it a valuable tool in research and diagnostic applications.
Podoplanin is a 140 amino acid protein with a molecular weight of approximately 36 kDa. It is characterized by its single-pass transmembrane domain and an extracellular domain that is heavily glycosylated. The extracellular domain contains three platelet aggregation-stimulating (PLAG) domains, which are responsible for its interaction with the C-type lectin-like receptor 2 (CLEC-2) on platelets . This interaction induces platelet aggregation and is crucial for maintaining the integrity of the lymphatic system.
Podoplanin is involved in various biological processes, including:
The mouse anti-human podoplanin antibody is a monoclonal antibody that specifically binds to human podoplanin. It is produced by immunizing mice with the human podoplanin ectodomain expressed in Escherichia coli. The antibody is then purified from the mouse serum using affinity chromatography.
The mouse anti-human podoplanin antibody is widely used in various research and diagnostic applications, including:
The mouse anti-human podoplanin antibody has been extensively validated for its specificity and performance. It has been shown to specifically bind to human podoplanin without cross-reacting with other proteins. The antibody’s specificity has been confirmed through various techniques, including relative expression analysis and knockdown experiments .